Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $378.61 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $226.61 | 2 | $0 (2023) |
| EISAI INC. | $46.19 | 2 | $0 (2022) |
| KLS-Martin L.P. | $23.20 | 1 | $0 (2022) |
| Genentech USA, Inc. | $21.16 | 1 | $0 (2019) |
| INSYS Therapeutics Inc | $16.23 | 1 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.20 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $15.56 | 1 | $0 (2019) |
| TESARO, Inc. | $13.46 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $163.68 | 1 | Stryker Corporation ($163.68) |
| 2022 | $48.27 | 2 | EISAI INC. ($25.07) |
| 2019 | $74.04 | 4 | Genentech USA, Inc. ($21.16) |
| 2018 | $29.69 | 2 | INSYS Therapeutics Inc ($16.23) |
| 2017 | $62.93 | 1 | Stryker Corporation ($62.93) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/21/2023 | Stryker Corporation | VSP SYSTEM, VSP CRANIAL (Device) | Food and Beverage | In-kind items and services | $163.68 | General |
| Category: CRANIOMAXILLOFACIAL | ||||||
| 11/04/2022 | KLS-Martin L.P. | — | Food and Beverage | Cash or cash equivalent | $23.20 | General |
| Category: CT Based Power | ||||||
| 01/21/2022 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $25.07 | General |
| Category: Oncology | ||||||
| 10/24/2019 | Genentech USA, Inc. | Perjeta (Biological), Kadcyla, TECENTRIQ | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: BioOncology | ||||||
| 10/01/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $16.20 | General |
| 07/11/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $21.12 | General |
| Category: Oncology | ||||||
| 06/17/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $15.56 | General |
| Category: Oncology | ||||||
| 08/31/2018 | INSYS Therapeutics Inc | SYNDROS (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
| 06/22/2018 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: ONCOLOGY | ||||||
| 03/09/2017 | Stryker Corporation | Customized Mandible Recon (Device), Universal Mandible, Hybrid MMF | Food and Beverage | Cash or cash equivalent | $62.93 | General |
| Category: Craniomaxillofacial | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 445 | 609 | $128,128 | $50,503 |
| 2022 | 6 | 389 | 546 | $62,350 | $30,662 |
| 2021 | 5 | 349 | 486 | $48,043 | $24,347 |
| 2020 | 4 | 345 | 466 | $78,558 | $31,695 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 38724 | Removal of lymph nodes, muscle, and tissue of neck | Facility | 2023 | 16 | 17 | $65,608 | $19,417 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 221 | 369 | $20,160 | $14,780 | 73.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 72 | 72 | $26,397 | $9,061 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 36 | 39 | $5,343 | $2,589 | 48.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 16 | 18 | $4,023 | $2,014 | 50.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 43 | 48 | $1,365 | $872.45 | 63.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 11 | 11 | $1,485 | $646.10 | 43.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Facility | 2023 | 15 | 15 | $987.00 | $562.50 | 57.0% |
| 92511 | Exam of the nose and throat using an endoscope | Facility | 2023 | 15 | 20 | $2,760 | $561.07 | 20.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 199 | 343 | $18,756 | $13,407 | 71.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 87 | 87 | $31,755 | $11,763 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 28 | 30 | $4,020 | $2,076 | 51.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 14 | 14 | $3,094 | $1,475 | 47.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 47 | 54 | $1,989 | $1,007 | 50.6% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Facility | 2022 | 14 | 18 | $2,736 | $935.57 | 34.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 157 | 256 | $14,643 | $10,543 | 72.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 65 | 65 | $23,959 | $8,833 | 36.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 96 | 134 | $4,069 | $2,740 | 67.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 14 | 14 | $3,094 | $1,401 | 45.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 17 | 17 | $2,278 | $831.05 | 36.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 145 | 243 | $32,679 | $14,123 | 43.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 74 | 74 | $27,244 | $9,673 | 35.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 52 | 55 | $12,155 | $4,410 | 36.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 74 | 94 | $6,480 | $3,489 | 53.8% |
About Dr. Thomas Shellenberger, MD
Dr. Thomas Shellenberger, MD is a Surgical Oncology healthcare provider based in Gilbert, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730141391.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Shellenberger, MD has received a total of $378.61 in payments from pharmaceutical and medical device companies, with $163.68 received in 2023. These payments were reported across 10 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($378.61).
As a Medicare-enrolled provider, Shellenberger has provided services to 1,528 Medicare beneficiaries, totaling 2,107 services with total Medicare billing of $137,208. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Surgical Oncology
- Other Specialties Surgery
- Location Gilbert, AZ
- Active Since 04/06/2006
- Last Updated 03/16/2015
- Taxonomy Code 2086X0206X
- Entity Type Individual
- NPI Number 1730141391
Products in Payments
- VSP SYSTEM, VSP CRANIAL (Device) $163.68
- Customized Mandible Recon (Device) $62.93
- Lenvima (Drug) $46.19
- Perjeta (Biological) $21.16
- SYNDROS (Drug) $16.23
- OPDIVO (Biological) $15.56
- ZEJULA (Drug) $13.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgical Oncology Doctors in Gilbert
Mark Gimbel, M.d, M.D
Surgical Oncology — Payments: $14,595
Dr. Epameinondas Dogeas, Md, MD
Surgical Oncology — Payments: $2,456
Julie Billar, M.d, M.D
Surgical Oncology — Payments: $818.50
Rajesh Ramanathan, Md, MD
Surgical Oncology — Payments: $324.27
Mrs. Sarianne Stradling, Pa-C, PA-C
Surgical Oncology — Payments: $187.89
Chynna Liu, Pa-C, PA-C
Surgical Oncology — Payments: $158.59